You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 143 No. 9, September 2007 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Correspondence
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone

Kalman L. Watsky, MD; Erin M. Warshaw, MD, MS

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the commentary in the March 2007 issue of the Archives of Dermatology titled "Topical Hydrocortisone From Prescription to Over-the-Counter Sale."1 While this article aptly describes the historical debate regarding approval for over-the-counter drug (OTC) use, it neglects to include allergic contact dermatitis from corticosteroids as 1 of the adverse effects of topical hydrocortisone.2-9

Corticosteroid allergy was first described in 1959 by Burckhardt10 but has become more widely recognized since the introduction of tixocortol-21-pivalate as a patch-test marker in the late 1980s. Prevalence of allergy to tixocortol, a marker for allergy to hydrocortisone and other group A corticosteroids, has ranged from 2.3% to 2.9% in large patch-tested populations in North America. Clinical relevance to the presenting dermatitis is documented in more than 80% of cases.

The ready availability of OTC hydrocortisone products likely contributes to this high prevalence . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone—Reply
William H. Eaglstein and Scott M. Ravis
Arch Dermatol. 2007;143(9):1217-1218.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Topical Hydrocortisone From Prescription to Over-the-Counter Sale: A Past Controversy: A Cautionary Tale
Scott Michael Ravis and William H. Eaglstein
Arch Dermatol. 2007;143(3):413-415.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.